South Korea Liquid Biopsy Market Size, Trends, Insights

According to a research report published by Spherical Insights & Consulting, The South Korea Liquid Biopsy Market Size is anticipated to reach USD 566.0 Million by 2035, growing at a CAGR of 10.33% from 2025 to 2035. Driven by the high rate of cancer, the growing need for non-invasive diagnostic techniques, and the robust government backing of R&D and precision medicine programs. Innovation and adoption are being further accelerated by technological developments in biomarker detection and expanding partnerships between biotech companies and academic institutions.